Burning Rock Biotech Limited (BNR)

R&D Expense Growth

-28.32%

Fiscal year · Period ending:

BNR logo

BNR R&D Expense Growth

Latest reported-28.32%
BNR FY R&D Growth (YoY) (0.00% → -28.32%)
High-resolution chart · PNG

BNR r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-28.3249%
-33.0607%
-17.743%
14.6823%
39.3718%
68.1843%
49.0375%
114.7995%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.